New criteria for amount of salt, sugar and saturated fat in foods The National Approach to Product Improvement (Nationale Aanpak Productverbetering, in Dutch NAPV) is set to start this year.
Impact of coronavirus outbreak on participation in National Immunisation Programme limited Participation in the vaccinations against mumps, measles and rubella (MMR) and diphtheria, pertussis (whooping cough), tetanus and polio) (DTaP-IPV) has decreased slightly among infants (-1%).
Omicron subvariant BA.2 becomes dominant, decrease in hospital admissions Since this week, the Omicron subvariant BA.2 has caused the most infections in the Netherlands. 1,149 patients with a SARS-CoV-2 infection were admitted to hospital in the Netherlands in the past week*, a decrease of 18% compared to the week before t
Increase in COVID-19 hospital admissions, positive tests reaching high plateau Last week*, 1,266 patients with a SARS-CoV-2 infection were admitted to hospital in the Netherlands, an increase of 7% compared to the week before that.
Over half a million positive COVID-19 tests, more hospital admissions Last week*, 530,015 positive COVID-19 tests were reported to RIVM**. That is an increase of 45% compared to the week before that. The number of new hospital admissions rose by 11% in the past week. ICU admissions rose by 18%.
First clients and care workers in mental healthcare vaccinated on Monday The first mental health clients in inpatient or residential care in four large institutions in the Netherlands will be vaccinated against COVID-19 this week.
RIVM collaborates at European level on the implemention of the Nutri-Score label The Netherlands, Belgium, France, Germany, Luxembourg, Spain and Switzerland are collaborating to facilitate the nutritional label NutriScore.
New research in GGD test lanes on spread of coronavirus SARS-CoV-2 RIVM is launching a survey-based study this week on risk factors for the coronavirus SARS-CoV-2. The participants in this study are people who get tested for COVID-19 in a GGD test lane.
New variants disrupt plans In the past week, from 27 January to 2 February, 28,628 people in the Netherlands reportedly tested positive for COVID-19, a 20% decrease compared to the week of 20 to 26 January.
One person died shortly after COVID-19 vaccination The Pharmacovigilance Centre Lareb announced today that the centre had received a report of death shortly after receiving the Pfizer/BioNTech COVID-19 vaccination in the Netherlands.